IMPORTANT DATES


  • Abstract Submission opens:

    February 20, 2019


  • Abstract Submission Deadline:

    October 05, 2019


  • Standard Registration opens:

    February 20, 2019


  • Standard Registration Deadline:

    October 05, 2019

  • Alzheimers 2019 provides a vibrant platform for sharing knowledge among the Neurodegenerative diseases, Dementia thus focusing on the New Research and Treatments. The workshops are designed for academia and industrial benefits who want to have updated knowledge on management and treatment techniques. The Conference gathers expert surgeons in the world to share their experience and guide participants to explore advanced surgical techniques.


    The Alzheimers 2019 invites abstracts related to the new scientific research in all the fields of Neuroscience, dementia and other degenerative diseases. Registrants are invited to submit an abstract for consideration for oral and poster presentation. In general we encourage more specific to the current research fields representing innovation and recent technologies. Abstracts received will be reviewed by scientific committee from aspirants and categorized as speaker talks and poster presentations.

    Kuala Lumpur is the capital of Malaysia. Its modern skyline is dominated by the 451m-tall Petronas Twin Towers, a pair of glass-and-steel-clad skyscrapers with Islamic motifs. The towers also offer a public sky bridge and observation deck. The city is also home to British colonial-era landmarks such as the Kuala Lumpur Railway Station and the Sultan Abdul Samad Building.


Alzheimer’s disease

Alzheimer's ailment is a neurological cerebrum issue. Alzheimer's sickness is the most widely recognized type of dementia, a gathering of scatters that disables mental working. Alzheimer's is dynamic and irreversible. Memory loss is one of the most punctual indications, alongside a progressive decay of other scholarly and thinking capacities, called intellectual capacities, and changes in identity or conduct.

Dementia

Dementia is a mutual phase used to describe the various syndrome of cognitive declines, such as inattention. Dementia is a syndrome not a disease. Dementia is a group of the syndrome that affects mental cognitive exercise such as memory and analysis. Dementia is caused by damage to brain cells.

Neurodegenerative diseases

The neurocognitive disorder was called as dementia in previously and the main ingredient of all neurocognitive disorders is a captured cognitive deterioration in one or more cognitive domains. The abstract discount must not simply be a feeling of lost psychological potential, yet noticeable by others and additionally tried by an intellectual appraisal. Neurocognitive disorders can affect feeling, language, thought, learning, memory & social cognition. They interfere automatically with a person’s everyday ability in major neurocognitive disorder, but not so in minor neurocognitive disorder.

Vascular Dementia

Vascular dementia is a decline in thinking skills caused by conditions that block or reduce blood flow to the brain, depriving brain cells of vital oxygen and nutrients. Inadequate blood flow can damage and eventually kill cells anywhere in the body. The brain has one of the body's richest networks of blood vessels and is especially vulnerable. 

Dementia with Lewy Bodies

Lewy body dementia (LBD) is a type of progressive dementia that leads to a decline in thinking, reasoning and independent function because of abnormal microscopic deposits that damage brain cells over time. Most experts estimate that Lewy body dementia is the third most common cause of dementia after Alzheimer's disease and vascular dementia, accounting for 10 to 25 percent of cases.

Frontotemporal dementia

Frontotemporal dementia (FTD) or frontotemporal degenerations refers to a group of disorders caused by progressive nerve cell loss in the brain's frontal lobes (the areas behind your forehead) or its temporal lobes (the regions behind your ears). The nerve cell damage caused by frontotemporal dementia leads to loss of function in these brain regions, which variably cause deterioration in behavior and personality, language disturbances, or alterations in muscle or motor functions.

Parkinson’s disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Parkinson's disease (PD) likewise has a few non-engine highlights, including psychological wellness issues, rest unsettling influences and autonomic aggravations. At introduce, there is no cure for PD. The treatment is, subsequently, gone from treating side effects. There are right now two fundamental ways to deal with enhanced dopaminergic action inside the mind: expanding dopamine emission with exogenous operators and focusing on related neurotransmission pathways. Levodopa is the regular metabolic antecedent of dopamine and is profoundly successful for treating PD indications.

Geriatric and Cognitive Disorder

Geriatrics is the branch of medicine or social science dealing with the health and care of old people. Cognitive disorders are a group of mental health disorders that primarily affect learning, memory, perception, and problem solving, and include amnesia, dementia, and delirium. Neurocognitive disorders have delirium and main neurocognitive disorder. They are defined by the loss in cognitive ability that is collected, mostly be decline and may have a basic brain pathology. The DSM-5 defines six key domains of cognitive action: executive action, learning & memory, perceptual-motor function, language, complex attention, and social cognition.

Behavioral Problems in Alzheimer’s disease

As Alzheimer's and other dementias progress, behaviors change—as does your role as caregiver. While changes in behavior can be challenging, we have resources to help you through each stage of the disease. Alzheimer’s disease leads to progressive deterioration in the brain, which causes problems with memory and cognition. Even more heartbreaking, these changes to the brain can cause a range of behavioral issues. Caregivers of Alzheimer’s patients may find their loved ones acting in unfamiliar, even disturbing or violent ways. Sometimes the behavior is so severe that families place Alzheimer’s patients in nursing homes or dementia care facilities.

Alzheimer’s disease and Type 2 Diabetes

The link between Alzheimer’s and diabetes continues to grow stronger. Hyperinsulinemia, caused by early or undiagnosed diabetes, obesity or prediabetes is also found in nearly half of all people with Alzheimer’s.  Scientists are finding more evidence that could link Type 2 diabetes with Alzheimer’s disease, the most common form of dementia and the seventh leading cause of death in the United States. Several research studies following large groups over many years suggest that adults with Type 2 diabetes have a higher risk of later developing Alzheimer’s. Alzheimer’s disease is a progressive and fatal brain disorder that gradually destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. As Alzheimer’s progresses, individuals may have changes in personality and behavior, such as anxiety, suspiciousness or agitation, as well as delusions.

Insulin Resistance on the development of Alzheimer’s disease

Considering the strong links between hyperinsulinaemia/insulin resistance (IR) and development of Alzheimer’s disease, it is not surprising that type 2 diabetes (T2D) is a significant risk factor for AD. However, a diagnosis of T2D is not required for eventual progression to AD, because T2D does not cause AD. Rather, they may be thought of as ‘physiological cousins’ – conditions that result from the same underlying metabolic disturbances, but which have different outward manifestations in the body. One may be a diagnosed T2 diabetic and not develop AD, and many AD patients are not diagnosed diabetics.

Pathophysiology and Disease Mechanisms

Alzheimer's disease (AD) is a progressive dementia with loss of neurons and the presence of two main microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, the rare familial form, is the result of a mutation in one of three gene. AD's core neuropathologic findings include extracellular amyloid plaques, intracellular NFTs, synaptic deterioration, and neuronal death.1 Granulovacuolar degeneration in the hippocampus and amyloid deposition in blood vessels (congophilic angiopathy) may also be seen on tissue examination, but are not required for the diagnosis.4 The "amyloid cascade" hypothesis posits that amyloid plaques interfere with synaptic activity and initiate a series of downstream effects that cause increasing inter- and intraneuronal dysfunction and, ultimately, cell death.

Diagnosis and Symptoms

Early signs and symptoms of Alzheimer's dementia includes Memory impairment, such as difficulty remembering events; Difficulty concentrating, planning or problem-solving; Problems finishing daily tasks at home or at work; Confusion with location or passage of time; Having visual or space difficulties, such as not understanding distance in driving, getting lost or misplacing items; Language problems, such as word-finding problems or reduced vocabulary in speech or writing; Using poor judgment in decisions;; Withdrawal from work events or social engagements; Changes in mood, such as depression or other behaviour and personality changes. Diagnosing Alzheimer's dementia Whether you have impaired memory or thinking (cognitive) skills Whether you exhibit changes in personality or behaviours; The degree of your memory or thinking impairment or changes; How your thinking problems affect your ability to function in daily life; The cause of your symptoms.

Alzheimer’s Rehabilitation and Therapy

Novel therapeutics is a standout between the most activation uses of data preparing frameworks is in diagnostics and treatment. This is not extraordinary, given that illness investigation is in its center a data handling undertaking that ending with a choice. In numerous infections, the completion can be performed in singular cells. We are used to thinking of rehabilitation in terms of physical rehabilitation following injury, but it is equally relevant for people with cognitive, rather than physical deterioration. This includes people whose deterioration result from long-term, progressive neurodegenerative conditions. In cognitive rehabilitation, these principles are applied to enable people with dementia to maintain or develop functioning.

Care, Practice and Awareness

Persons with dementia have multiple psychological feature deficits that include each memory impairment, that affects the flexibility to find out new info or recall information previously learned, and one or additional of the subsequent symptoms-aphasia, apraxia, agnosia, or executive dysfunction-such that the psychological feature deficits negatively have an effect on social or activity functioning with a big decline in previous talents. Additionally, persons with dementia typically suffer from comorbid conditions that additional complicate care and impede best outcomes. Therefore, developing caregiving methods people with dementia is urgent, given this increasing prevalence and therefore the associated burden that dementia places not only on the individuals, however on the caregivers, relations, and therefore the resources of the health care system. Conventional views bearing on geriatric nursing typically paint an image of the care as being slow paced certain and less demanding than acute care. However, care of the aged, and particularly those with dementia, is usually complicated, unpredictable, and unstable.

Current Research in Therapeutic Targets

Treatment for Alzheimer's disease is entering a new and exciting phase, with several new drugs beginning clinical trials. Many of these new therapies are based on our best current understanding of the pathogenesis of Alzheimer's disease, and are designed to try to either slow or halt the progression of the disease. There are several different theories underlying the current efforts, and these are briefly reviewed. Therapies directed against some aspect of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response are all considered, as are the problems associated with each area. It is yet unclear which, if any of these approaches will be successful, but the high level of activity in each of these three fields provides some hope that an effective treatment for Alzheimer's disease is on the horizon.

Neurodegenerative Clinical Trials and Studies

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several etiologies of which Alzheimer’s disease (AD) is the most common.

Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuro-inflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.


 

Attendee Criteria

Attendees would be active researchers, industrialists, scientists, associations, societies, PhD and post doc fellows, students, faculty, Subject experts and Entrepreneurs. Authors of accepted abstracts are pre-approved for registration. All other researchers must Sign up and register towards the conference.

A very limited number of spots are available for individuals in Keynote/Plenary positions.  Some of the Keynote and Plenary Speakers will have an opportunity to chair any session during the conference.

25 Oral presentation spots are available for 2-day events. The individual speaker is allowed to present a maximum of 2 talks at the conference.

 

Who Can Attend

Researcher/Academic /Industrial / Clinical / Private / Marketing

Researchers actively participating in basic science investigations, clinical studies, or epidemiologic research.

 

Physicians & Scientists who have faculty appointments at academic institutions including medical school programs, or practitioners who are involved in patient care or counselling.

 

Industries related to pharmaceuticals, Manufacturing, Services, Clinical can achieve visibility and credibility, exhibiting at a trade show has hundreds of benefits for your business. Establishing a presence, whether big or small, for your company at an exhibition gives you a powerful platform for meeting new customers, reaching out to your existing clients, and building a more established and reliable brand.

 

Clinical takes advantage of the educational and networking opportunities designed for hospital professional.

 

Marketers from generating new business to staying current with the latest trends, attending marketing events, meetings, and conferences can be crucial to the success of a company’s or individual’s growth strategy. There are some key benefits for why marketers should consider attending networking events.

 

1. Build Meaningful Relationships

2. Stay Current with Trends by Learning from Powerful Speakers

3. Connect with Influencers and in Turn, You’re Target Audience

4. Get Fresh Ideas and Solutions for Your Business.

 

Various sessions in our Conferences:

Plenary Talk: A plenary talk of a conference which all members of all parties are to attend. Such a session may include a broad range of content, from keynotes to panel discussions, and is not necessarily related to a specific style of presentation or deliberative process.





Keynote: This is a talk on a specific theme which represent the whole subject of the conference. Keynotes are usually delivered by Professors, President of associations, MD and above.



Oral Presentation: A presentation is a process of presenting a topic to an audience. It is typically a demonstration, introduction, lecture, or speech meant to inform, persuade, inspire, motivate, or to build goodwill or to present a new idea or product.



Delegate: One who gains knowledge, comprehension or mastery through experience or study; someone who learns or takes knowledge or beliefs; one that is learning; one that is acquiring new knowledge, behaviour’s, skills, values or preferences.



Poster Presentation: A poster presentation, at a congress or conference with an academic or professional focus, is the presentation of research information, usually peer-reviewed work, in the form of a poster that conference participants may view. A poster session is an event at which many such posters are presented.



Workshop: A workshop is designed to teach something or develop a specific skill while an academic conference is about presenting original research and getting feedback from peers. A workshop doesn't necessarily have to present original research; it is directed more towards teaching and learning in an interactive environment.



E-poster: An e-Poster or digital poster is a digital presentation of research that is presented within a congress.



Video Presentation: Animated or recorded video describing a research or review topic. Video talks for usually not more than 20-30mins)

 

Contact Us

Enter your details for subscription

Supporting Journals

journals (2).jpg

A journal is your completely unaltered voice embracing and rewarding your scientific knowledge

Exhibitions

exhi.jpg

Serve as an influential platform for companies & professional experts to come together and build long-lasting relationships

Networking & Marketing

Networking (2).jpg

Talking to strangers without being awkward is way easier at conferences

Kuala Lumpur

Kuala Lumpur 21.jpg

Kuala Lumpur is the capital of Malaysia. Its modern skyline is dominated by the 451m-tall Petronas Twin Towers, a pair of glass-and-steel-clad skyscrapers with Islamic motifs. The towers also offer a public sky bridge and observation deck. The city is also home to British colonial-era landmarks such as the Kuala Lumpur Railway Station and the Sultan Abdul Samad Building.

Venue

WILL BE UPDATED.jpg

.

Recent Updates

alzheimers disease.jpg

Check out for regular update regarding the conference along with latest news, research, innovation in the field of Nursing Alzheimer's and Dementia.

MEDIA PARTNERS


EXHIBITORS


SPONSORS